An artificial pancreas is a device that regulates the amount of sugar in the body. It is made up of a sensor that transmits data about blood glucose levels to a computerised controller. This enables diabetics to live their lives normally, free of the constant anxiety of elevated blood sugar levels. It also enables diabetic people to have surgery or recover from injuries without jeopardising their lives or limb. The artificial pancreas gives doctors greater control over their patients' health.

A number of companies create artificial pancreas systems. These devices are intended for use in the treatment of diabetes, but they can also be used to monitor blood sugar levels in persons who do not have diabetes.

The primary goal of an artificial pancreas is to offer controlled insulin and medication delivery. This reduces the need for several injections and prevents harmful rises in blood glucose levels. The dose and timing of the medications can also be adjusted based on the patient's condition. People with type 1 and type 2 diabetes can now better control their symptoms.

Advantages

Diabetes patients can have normal, active lifestyles without concern of high blood glucose levels. This enables patients to pursue healthcare objectives such as weight loss or rehabilitation for chronic sickness problems such as heart failure or chronic obstructive pulmonary disease. It also permits diabetics to give birth without risking mortality due to excessive blood sugar levels during childbirth. The artificial pancreas aids in the regulation of blood sugar levels.

Disadvantages

When compared to alternatives such as continuous glucose monitoring systems, the necessity for regular calibrations and modifications, as well as a high cost of ownership (CGMSs). There is also debate about the effectiveness, safety, ethics, and regulatory status of manufactured APSs produced by various companies, particularly safety concerns about how the various components interact with one another when producing hyperglycemia-induced diabetic coma and death for those physically dependent on insulin for sustained life, necessitating periodic calibration against calibrated reference intervals and proof testing prototyping.